Sign in
4

Changes in Ownership

Processa Pharmaceuticals, Inc. Filed Acc 0000897069-26-000912

Pres. Research & Development bought 1,545 shares at $2.97 ($4,589)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Young David Pres. Research & Development 2026-04-15 Purchase +1,545 $2.97 $4,589 12,107 D
Open-market purchases · 1,545 sh · avg $2.97 · $4,589
Loading xslF345X06/form4.xml…